Abstract
The compound 17 cyano-5,16 androstadien-3β-ol-3-acetate (cyanoacetate) was considered as a promising candidate for use as a contraceptive agent, since it was reported to specifically inhibit the ovarian conversion of pregnenolone to progesterone. A preliminary study in rats indicated that this compound had unique properties that interfered with the interpretation of results concerning the decidual response. It appeared to interact with the ovaries of the animal to cause an increase in uterine weight. Because of these observations, a multiple factorial study was designed to determine whether this compound was, in fact, more uterotrophic in intact, than in spayed, pseudopregnant rats. The study demonstrated that the presence of the ovary resulted in a significantly greater uterine weight, while 2 mg progesterone daily for 10 days had no significant effect on uterine weight. Cyanoacetate (10 mg/day for 10 days) was found to increase uterine weight significantly in intact, but not spayed, pseudopregnant rats. Neither cyanoacetate (10 mg/day) nor progesterone (2 mg/day) affected ovarian weight. The data suggest that cyanoace- tate is converted by the ovary from a compound with little uterotrophic activity to a material with substantial uterotrophic activity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Brooks J.R., Babiarz E.M., Berman C., Primka R.L., Rasmusson G.H. Some endocrinological and anti-fertility properties of an androstane cyanohydrin derivative in the rat. Biol. Reprod. 18: 186, 1978.
Kendle K.E. Further investigation of the antifertility effects in the rat of the antiprogestational steroid, RMI 12, 936, and related compounds. J. Reprod. Fertil. 52: 373, 1978.
Goldman A.S. Active-site-directed-irreversible (ASDI) inhibition of 3β-hydroxy-steroid dehydrogenase, 17β-hydroxysteroid dehydrogenase and C17–20 lyase in testicular microsomes of the rat. The Endocrine Soc. 53rd Ann. Meeting, (Abstract 14), 1971.
Gustafsson J.A. Steroidal excretion patterns of rats treated with candidates for active-site-directed-irreversible (ASDI) inhibitors of steroidogenesis. The Endocrine Soc. 53rd Ann. Meeting, (Abstract 15), 1971.
Goldman A.S., Gustafsson J.A., Gustafsson S.A. New synthetic steroids which inhibit rat gonadal steroidogenic enzymes both in vitro and in vivo. Acta Endocrinol. (Kbh.) 73: 146, 1973.
Miramontes L., Aguinaco P., Romero M.A. Synthesis of 6-methyl steroids. J. Am. Chem. Soc. 82: 6153, 1960.
Steel R.G.D., Torrie J.H. Principles and procedures of statistics. McGraw-Hill, New York, 1960, p. 194.
Daniel S.A.J., Armstrong D.T. Enhancement of follicle-stimulating hormone-induced aromatase activity by androgens in cultured rat granulosa cells. Endocrinology 107: 1027, 1980.
Nalbandov A.V. Control of luteal function in mammals. In: Greep R.O., Astwood E.B. (Eds.), Handbook of physiology. Williams & Wilkins Co., Baltimore, 1973, Vol. 2, p. 153.
Gibori G., Antczak E., Rothchild I. The role of estrogen in the regulation of luteal progesterone secretion in the rat after day 12 of pregnancy. Endocrinology 100: 1483, 1977.
Robson J.M. Mechanism by which progesterone and other steroids inhibit the vaginal action of oestradiol. J. Endocrinol. 6: 449, 1950.
Alloiteau J.J., Acker G. Sur la secretion oestrogenique du corps jaune de la ratte recevant divers androgenes. C.R. Acad. Sci. (Paris) 250: 1566, 1960.
Harper M.J.K. Effects of androstenedione on pre-implantation stages of pregnancy in rats. Endocrinology 81: 1091, 1967.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bennett, D.R., Debono, M., Powell, J.G. et al. Effects of the interaction of the ovary with an androstane nitrile on the uterus of the rat. J Endocrinol Invest 5, 223–226 (1982). https://doi.org/10.1007/BF03348327
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348327